| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.66▼ | 0.67▼ | 0.67▼ | 0.69▼ | 2.51▼ |
| MA10 | 0.67▼ | 0.68▼ | 0.68▼ | 0.66▼ | 4.20▼ |
| MA20 | 0.68▼ | 0.69▼ | 0.70▼ | 2.35▼ | 3.78▼ |
| MA50 | 0.70▼ | 0.68▼ | 0.66▼ | 4.19▼ | 2.86▼ |
| MA100 | 0.69▼ | 0.69▼ | 1.67▼ | 3.72▼ | 3.43▼ |
| MA200 | 0.65▼ | 2.41▼ | 3.78▼ | 3.06▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.005▼ | 0.000▼ | -0.069▼ | -0.538▼ |
| RSI | 32.866▼ | 37.455▼ | 38.363▼ | 20.750▼ | 32.199▼ |
| STOCH | 10.554▼ | 10.387▼ | 11.284▼ | 30.302 | 29.117 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -97.287▼ | -98.046▼ |
| CCI | -153.212▼ | -158.462▼ | -144.583▼ | -45.218 | -148.386▼ |
|
Tuesday, September 02, 2025 04:00 AM
LA JOLLA, Calif., Sept. 2, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 0.671 | 0.681 | 0.6506 | 0.6506 | 355,835 |
| 12/02/26 | 0.69 | 0.725 | 0.66 | 0.70 | 193,568 |
| 11/02/26 | 0.77 | 0.7796 | 0.6856 | 0.697 | 405,193 |
| 10/02/26 | 0.6752 | 0.79 | 0.6521 | 0.7368 | 838,434 |
| 09/02/26 | 0.6255 | 0.68 | 0.6035 | 0.6528 | 302,838 |
| 06/02/26 | 0.58 | 0.65 | 0.5797 | 0.6001 | 566,833 |
| 05/02/26 | 0.6295 | 0.6568 | 0.5201 | 0.6109 | 833,506 |
| 04/02/26 | 0.60 | 0.72 | 0.5901 | 0.66 | 795,251 |
| 03/02/26 | 0.65 | 0.6698 | 0.599 | 0.609 | 1,251,577 |
| 02/02/26 | 0.85 | 0.8548 | 0.5931 | 0.67 | 2,228,346 |
|
|
||||
|
|
||||
|
|